K vs PAHC · P/E 23, $29.03B cap vs P/E 13, rev $1.52B
Kellanova (K) versus Phibro Animal Health Corporation (PAHC) — a side-by-side from cached financials, not a winner call.
Kellanova (K) is a packaged foods company listed on US.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
K does not have a complete income-statement cache yet.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
K currently screens at market cap $29.03B and trailing P/E 22.8. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Not investment advice. Open the K and PAHC stock pages for the full models.
Not investment advice.